HSDT Helius Medical Technologies, Inc. Stock Quote

HSDT [NASD]

Index	-	P/E	-	EPS (ttm)	-12.74	Insider Own	0.60%	Shs Outstand	1.29M	Perf Week	-3.33%
Market Cap	41.66M	Forward P/E	-	EPS next Y	-5.93	Insider Trans	0.00%	Shs Float	-	Perf Month	22.92%
Income	-14.10M	PEG	-	EPS next Q	-1.77	Inst Own	11.60%	Short Float	-	Perf Quarter	12.52%
Sales	0.70M	P/S	59.51	EPS this Y	70.50%	Inst Trans	61.90%	Short Ratio	0.29	Perf Half Y	15.28%
Book/sh	2.48	P/B	7.03	EPS next Y	-	ROA	-227.00%	Target Price	-	Perf Year	80.96%
Cash/sh	1.13	P/C	15.43	EPS next 5Y	-	ROE	-369.00%	52W Range	9.10 - 34.00	Perf YTD	32.24%
Dividend	-	P/FCF	-	EPS past 5Y	15.50%	ROI	-413.70%	52W High	-48.74%	Beta	0.81
Dividend %	-	Quick Ratio	1.40	Sales past 5Y	-	Gross Margin	41.40%	52W Low	91.54%	ATR	1.18
Employees	19	Current Ratio	1.60	Sales Q/Q	-50.00%	Oper. Margin	-	RSI (14)	58.21	Volatility	5.56% 8.03%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	64.30%	Profit Margin	-	Rel Volume	0.44	Prev Close	17.28
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Mar 10 AMC	Payout	-	Avg Volume	99.88K	Price	17.43
Recom	-	SMA20	7.99%	SMA50	17.15%	SMA200	13.74%	Volume	43,865	Change	0.87%

Mar-24-21

Initiated

Noble Capital Markets

Outperform

$20

Apr-07-21 04:30PM	Helius Medical Technologies, Inc. to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021 GlobeNewswire
Mar-29-21 06:30AM	Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS Device GlobeNewswire -7.56%
Mar-17-21 04:05PM	Helius Medical Technologies, Inc. to Present at the Investor Summit Groups Q1 Virtual Summit on March 23rd GlobeNewswire
07:05AM	Helius Medical Technologies, Inc. Appoints Sherrie Perkins to its Board of Directors GlobeNewswire
Mar-10-21 04:05PM	Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results GlobeNewswire -7.36%
Feb-22-21 12:45AM	Media Advisory - Imagery and video footage of the arrival of the COVID-19 vaccine CNW Group
Feb-02-21 07:30AM	Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021 GlobeNewswire
Feb-01-21 05:15PM	Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option GlobeNewswire
Jan-28-21 08:41AM	IIROC Trade Resumption - HSM CNW Group -10.19%
08:30AM	Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At Market GlobeNewswire
Jan-20-21 07:05AM	Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices GlobeNewswire
Jan-19-21 07:05AM	Helius Medical Technologies, Inc. Regains Compliance with Nasdaq Listing Standards GlobeNewswire +7.39%
Jan-15-21 12:37PM	Helius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor Conference GlobeNewswire
Jan-13-21 07:00AM	Sidoti Virtual Investor Conference ACCESSWIRE
Jan-11-21 07:05AM	Helius Medical Technologies, Inc. Submits Response to U.S. FDA in Pursuit of De Novo Classification and Clearance of the PoNS Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis GlobeNewswire +7.72%
Jan-05-21 04:05PM	Helius Medical Technologies, Inc. Comments on Unusual Market Activity GlobeNewswire +63.40%
Jan-04-21 07:05AM	Helius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in January GlobeNewswire -14.80%
Dec-31-20 07:05AM	Helius Medical Technologies, Inc. Announces Reverse Stock Split GlobeNewswire -10.12%
Nov-19-20 06:45AM	Sidoti Virtual Microcap Investor Conference ACCESSWIRE
Nov-12-20 04:05PM	Helius Medical Technologies, Inc. Reports Third Quarter of Fiscal Year 2020 Financial Results GlobeNewswire
09:20AM	Helius Medical Technologies to Present at the virtual Fall Investor Summit on November 16th-18th ACCESSWIRE
Nov-05-20 07:05AM	Helius Medical Technologies, Inc. to Present at Upcoming Investor Conferences in November GlobeNewswire
Nov-04-20 07:05AM	Helius Medical Technologies, Inc. Announces the Expansion to a Total of 27 Authorized PoNS Treatment Clinic Locations Across Canada GlobeNewswire
Nov-02-20 05:00PM	Helius Medical Technologies to Release Third Quarter of Fiscal Year 2020 Financial Results on November 12, 2020 GlobeNewswire
Oct-26-20 05:45PM	Helius Medical Technologies Announces Closing of $3.4 Million Private Placement GlobeNewswire -5.30%
Oct-21-20 04:32PM	Helius Medical Technologies Announces $3.4 Million Private Placement GlobeNewswire
Oct-19-20 05:17PM	10 Stocks Moving In Monday's After Hours Session Benzinga +7.59%
04:32PM	Helius Medical Technologies, Inc. Provides Update on FDAs Review of its Request for De Novo Classification and Clearance of the PoNS Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis GlobeNewswire
Oct-14-20 07:05AM	Helius Medical Technologies, Inc. Announces Partnership with Breakthrough Health for Multiple Sclerosis Insights GlobeNewswire
Oct-08-20 07:30AM	Helius Medical Technologies, Inc. Announces Formation of Multiple Sclerosis Scientific Advisory Board GlobeNewswire +8.67%
Sep-08-20 07:05AM	Helius Medical Technologies, Inc. Announces Publication of Peer-Reviewed Study: Translingual Neural Stimulation with the Portable Neuromodulation Stimulator (PoNS) Induces Structural Changes Leading to Functional Recovery in Patients with Mild-to-Moderate Traumatic Brain Injury GlobeNewswire +9.90%
Sep-02-20 06:21PM	LD Micro 360 Companies --Set to Present this Week. ACCESSWIRE -11.09%
Aug-31-20 02:00PM	Helius Medical Technologies, Inc. to Present at Three Upcoming Investor Conferences in September GlobeNewswire
Aug-25-20 07:05AM	Helius Medical Technologies, Inc. Announces Departure of President, Chief Executive Officer and Chairman Philippe Deschamps; Board of Directors Appoints Dane C. Andreeff as Interim President and Chief Executive Officer and Appoints Blane Walter as Chairman of the Board of Directors GlobeNewswire
Aug-12-20 06:05PM	Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Tops Revenue Estimates Zacks -10.40%
04:05PM	Helius Medical Technologies, Inc. Reports Second Quarter of Fiscal Year 2020 Financial Results GlobeNewswire
Aug-10-20 07:05AM	Helius Medical Technologies to Release Second Quarter of Fiscal Year 2020 Financial Results on August 12, 2020 GlobeNewswire
Aug-06-20 12:30PM	Helius Medical Technologies, Inc. (HSDT) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Zacks -7.23%
07:05AM	Helius Medical Technologies, Inc. Submits Request for FDA Clearance for PoNS Device; Reports Preliminary Financial Results for the Second Quarter and Six Months Ended June 30, 2020 GlobeNewswire
Aug-05-20 03:34PM	LD Micro-Announces Preliminary List of Presenters for the LD 500. ACCESSWIRE
Jul-14-20 07:05AM	Helius Medical Technologies Announces the Dismissal of the Shareholder Class Action Lawsuit GlobeNewswire +10.38%
Jun-15-20 07:00AM	INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Helius Medical Technologies, Inc. for Potential Breach of Fiduciary Duty Claims GlobeNewswire +7.06%
Jun-05-20 02:49PM	Hedge Funds Are Nibbling On Helius Medical Technologies, Inc. (HSDT) Insider Monkey
07:05AM	Helius Medical Technologies to Present at the Virtual Summer Summit on June 9th GlobeNewswire
Jun-03-20 09:00AM	47 Public Companies to present at the Summer Virtual Investor Summit on June 9th-12th ACCESSWIRE
May-12-20 07:05AM	Helius Medical Technologies, Inc. Announces FDA Has Granted the PoNS Device Breakthrough Device Designation for the Treatment of Gait Deficits Due to Symptoms of Multiple Sclerosis GlobeNewswire +52.94%
May-07-20 04:05PM	Helius Medical Technologies, Inc. Reports First Quarter of Full Year 2020 Financial Results; Updates Full Year 2020 Outlook GlobeNewswire
May-04-20 08:55AM	Before You Buy Helius Medical Technologies, Inc. (NASDAQ:HSDT), Consider Its Volatility Simply Wall St.
Apr-30-20 07:05AM	Helius Medical Technologies, Inc. Announces Publication of its PoNS Registrational Clinical Trial (TBI-001) in TBI GlobeNewswire +6.16%
Apr-22-20 04:05PM	Helius Medical Technologies to Release First Quarter of Fiscal Year 2020 Financial Results on May 7, 2020 GlobeNewswire
07:05AM	Helius Medical Technologies Appoints Jeffrey S. Mathiesen to its Board of Directors GlobeNewswire
Mar-24-20 07:05AM	Helius Medical Technologies Announces Authorization from Health Canada to Market the PoNS Device for the Treatment of Gait Deficit Due to Mild and Moderate Multiple Sclerosis (MS) GlobeNewswire
Mar-18-20 08:00AM	Helius Medical Technologies Announces $2.2 Million Registered Direct Offering GlobeNewswire -34.18%
Mar-15-20 09:57AM	Can Helius Medical Technologies (NASDAQ:HSDT) Fund Its Growth Plans? Simply Wall St.
Mar-12-20 04:05PM	Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results; Introduces Full Year 2020 Outlook GlobeNewswire -7.55%
Mar-09-20 07:05AM	Helius Medical Technologies, Inc. Provides Details on Five Recently Authorized PoNS Treatment Clinics GlobeNewswire -9.84%
Mar-02-20 07:59AM	Helius Medical Technologies Reports Preliminary Unaudited Fourth Quarter and Full Year Unaudited 2019 Financial Results, Provides Commercial and Regulatory Update and Announces Submission to Health Canada for Multiple Sclerosis (MS) Label Expansion and New US Regulatory Prioritization for MS GlobeNewswire -6.59%

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience